Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. Academic Article uri icon

authors

start page

end page

abstract

  • Genetic variation at the TERT-CLPTM1L locus at 5p15.33 is associated with susceptibility to several cancers, including epithelial ovarian cancer (EOC). We have carried out fine-mapping of this region in EOC which implicates an association with a single nucleotide polymorphism (SNP) within the TERT promoter. We demonstrate that the minor alleles at rs2736109, and at an additional TERT promoter SNP, rs2736108, are associated with decreased breast cancer risk, and that the combination of both SNPs substantially reduces TERT promoter activity.

date/time value

  • 2011

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0024987

PubMed Identifier

  • 21949822

volume

  • 6

number

  • 9

keywords

  • Breast Neoplasms
  • Case-Control Studies
  • Cystadenocarcinoma, Serous
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Telomerase